First Time US Pharmaceuticals (India) Private Limited is a research-driven pharmaceutical organization focused on developing high-quality generic medicines and advanced innovative drug delivery technologies for regulated markets. Based in Navi Mumbai, Maharashtra, India, the company plays a vital role in supporting pharmaceutical innovation by offering formulation development, analytical services, and regulatory expertise to global Markets and global partners.
As a subsidiary of the U.S.-based pharmaceutical company, USpharma Limited headquartered in Miami, Florida, United States, the organization contributes to the development of innovative and cost-effective medicines intended for regulated international markets. This strategic relationship enables strong collaboration between research teams in India and global pharmaceutical partners, accelerating the development and commercialization of generic medicines.
Expertise in Pharmaceutical Formulation Development
The company focuses on pharmaceutical formulation development across multiple dosage forms, including solid oral dosage forms, chewable tablets, taste-masked drug delivery systems, transdermal, semisolid and other patient-friendly formulations. Through advanced formulation technologies and scientific expertise, the organization aims to address challenges such as poor solubility, bitterness of active pharmaceutical ingredients, and product stability.
Key areas of expertise include:
- Solid oral dosage forms
- Soft chewable tablets
- Taste-masked drug delivery systems
- Transdermal patches
- Advanced solubility enhancement technologies
These innovations help improve patient compliance, drug stability, and therapeutic effectiveness, especially for drugs with complex formulation challenges.
Supporting Global Generic Drug Development
With a strong commitment to advancing accessible healthcare, First Time US Pharmaceuticals (India) Private Limited continues to strengthen its research capabilities and global collaborations. Through innovation, expertise, and strategic partnerships, the company contributes to the development of affordable medicines that improve patient care worldwide.
Commitment to Quality and Compliance
Quality and regulatory compliance are central to every stage of the development process. The company operates under robust quality management systems designed to meet international pharmaceutical standards.
Through strict adherence to regulatory guidelines and continuous improvement practices, the organization ensures the safety, efficacy, and reliability of its pharmaceutical products and services.
Advancing the Future of Affordable Medicines
As global healthcare systems continue to emphasize access to affordable treatments, companies involved in generic drug development play a critical role in addressing this demand.
First Time US Pharmaceuticals (India) Private Limited remains committed to innovation, research excellence, and strategic collaborations. By investing in advanced pharmaceutical technologies and expanding its research capabilities, the company aims to contribute significantly to the future of accessible and high-quality medicines worldwide.